We are monitoring the impact of COVID-19 on MEA Antifungal Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 217
Share on
Share on

Middle East & Africa Antifungal Drugs Market Research Report – Segmented By Drug Type, Therapeutic Indications, Application & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 217
Pages: 145

MEA Antifungal Drugs Market Size (2021 to 2026)

As per the report published, the size of the Antifungal Drugs Market in the Middle East and Africa was worth USD 1.08 billion in 2021 and estimated to be growing at a CAGR of 3.462%, to reach USD 1.28 billion by 2026. In the next few years, the market is expected to grow enormously with the growing global population.

Antifungal drugs are commonly used to cure fungal infections due to unclean, unhygienic, and damp environments. Invasion of epithelial tissue by microscopic organisms leads to fungal infections. Systemic fungal infections are caused due to indigestion or inhalation of spores, leading to fungal pneumonia, and diseases like candidaisis, meningitis, mucormycosis, etc., are caused by opportunistic fungus. Although most fungal infections and diseases are commonly non-lethal, they are very uncomfortable to the host, and their common occurrence is responsible for the rising antifungal drugs market. Antifungal drugs work via various mechanisms by inhibiting cell wall formation, cell membrane disruption, and cell division.

The major factors driving the market are increasing awareness of fungal infections with the growing incidence rate of antifungal infections all over the world, increasing government and corporate funds in the industry. The development of public-private partnerships in the pharmaceutical industry and the rising popularity of over-the-counter antifungal drugs for dermal infections are vastly responsible for the growing antifungal drug market size. Also, the rising population with a weak immune system, in whom fungal infections are much more than average, will drive the market. The high prevalence of conventional drugs used for the treatment of fungal infections is significantly restraining market growth.

The cost of drugs and their effectiveness in treatments remain the challenges for the market.

This research report on the Middle East and Africa Antifungal Drugs Market has been segmented and sub-segmented into the following categories:

By Drug Type: 

  • Echinocandins
  • Azoles
  • Polyenes
  • Allylamines
  • Others

By Therapeutic Indications: 

  • Aspergillosis
  • Dermatophytosis
  • Candidiasis
  • Others

By Application: 

  • Powders
  • Ointments
  • Drugs
  • Pastes

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, the Middle East commands a major share in the region, and Africa is the fastest-growing region. Growing awareness of antifungal drugs is the major driver of the market in the region.

Companies such as Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Aspergillus, Kramer Laboratories, Bayer Healthcare, Enzon Pharmaceuticals, Glaxosmithkline Gilead and Abbott Laboratories are playing a significant role in the MEA antifungal drugs market.

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods          

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction               

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                       

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                    

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market              

5. Market Segmentation                              

                5.1 By Drug Type             

                                5.1.1 Echinocandins

                                5.1.2 Azoles

                                5.1.3 Polyenes

                                5.1.4 Allylamines

                                5.1.5 Others

                5.2 By Therapeutic Indications   

                                5.2.1 Aspergillosis

                                5.2.2 Dermatophytosis

                                5.2.3 Candidiasis

                                5.2.4 Others

                5.3 By Application           

                                5.3.1 Powders

                                5.3.2 Ointments

                                5.3.5 Drugs

                                5.3.4 Pastes

6. Geographical Analysis                              

                6.1 Introduction               

                6.2 Middle-East                

                6.3 Africa            

7. Strategic Analysis                       

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8. Market Leaders' Analysis                        

                8.1 Alternaria    

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Pfizer            

                8.3 Novartis       

                8.4 Sanofi-Aventis          

                8.5 Merck & Co.               

                8.6 Asperqillus  

                8.7 Kramer Laboratories               

                8.8 Bayer Healthcare     

                8.9 Enzon Pharmaceuticals          

                8.10 Glaxosmithkline Gilead       

                8.11 Abbott Laboratories             

9. Competitive Landscape                           

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis       

                9.3 Agreements, collaborations and Joint Ventures         

                9.4 New Product Launches         

10. Expert Opinions                        

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

 

  1. Middle East & Africa Antifungal Drugs Market, By Region, From 2021 to 2026 (USD Million)
  2. Middle East & Africa Antifungal Drugs Market, By Drug Type, From 2021 to 2026 (USD Million)
  3. Middle East & Africa Echinocandins Market, By Region, From 2021 to 2026 (USD Million)
  4. Middle East & Africa Azoles Market, By Region, From 2021 to 2026 (USD Million)
  5. Middle East & Africa Polyenes Market, By Region, From 2021 to 2026 (USD Million)
  6. Middle East & Africa Allylamines Market, By Region, From 2021 to 2026 (USD Million)
  7. Middle East & Africa Other Drugs Market, By Region, From 2021 to 2026 (USD Million)
  8. Middle East & Africa Antifungal Drugs Market, By Therapeutic Indications, From 2021 to 2026 (USD Million)
  9. Middle East & Africa Aspergillosis Market, By Region, From 2021 to 2026 (USD Million)
  10. Middle East & Africa Dermatophytosis Market, By Region, From 2021 to 2026 (USD Million)
  11. Middle East & Africa Candidiasis Market, By Region, From 2021 to 2026 (USD Million)
  12. Middle East & Africa Other Therapeutic Indications Market, By Region, From 2021 to 2026 (USD Million)
  13. Middle East & Africa Antifungal Drugs Market, By Application, From 2021 to 2026 (USD Million)
  14. Middle East & Africa Powders Market, By Region, From 2021 to 2026 (USD Million)
  15. Middle East & Africa Ointments Market, By Region, From 2021 to 2026 (USD Million)
  16. Middle East & Africa Drugs Market, By Region, From 2021 to 2026 (USD Million)
  17. Middle East & Africa Pastes Market, By Region, From 2021 to 2026 (USD Million)
  18. Middle East Antifungal Drugs Market, By Drug Type, From 2021 to 2026 (USD Million)
  19. Middle East Antifungal Drugs Market, By Therapeutic Indications, From 2021 to 2026 (USD Million)
  20. Middle East Antifungal Drugs Market, By Application, From 2021 to 2026 (USD Million)
  21. Africa Antifungal Drugs Market, By Drug Type, From 2021 to 2026 (USD Million)
  22. Africa Antifungal Drugs Market, By Therapeutic Indications, From 2021 to 2026 (USD Million)
  23. Africa Antifungal Drugs Market, By Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample